Hyperlipidemia plays an important role in the development of atherosclerosis, the main cause of death in the world. In this study, the lipid-lowering effect of Carica papaya leaf in rats fed with a high cholesterol diet was evaluated. Daily doses of C. papaya extract 0, 31, 62 or 125 mg/kg body weight were orally administered in 300 µl polyethylene glycol to hypercholesterolemic rats; it was also administered 62 mg/kg body weight of the extract to rats with normal diet. After a 20-day treatment, the animals were sacrificed; blood and liver were analyzed. Hypercholesterolemic rats showed an increased serum and liver cholesterol, triacylglycerols, and atherogenic index. The C. papaya extract produced a significant decrease of serum and liver cholesterol concentrations in hypercholesterolemic rats, but did not modify serum or liver triacylglycerols; however, the extract reduced the atherogenic index in a dose-dependent manner. C. papaya treatment decreased LDL-C and increased HDL-C in serum significantly. When the oxygen consumption was evaluated in phosphorylating and resting states, the respiratory control in hypercholesterolemic rats mitochondria was lower than in normal diet rats. However, a higher respiratory control in hypercho-* Corresponding author.
Introduction
Hyperlipidemia is the major contributor to cardiovascular disease (CVD). The risk factors for CVD include obesity, elevated blood pressure, high blood cholesterol, and diabetes; CVDs are among the leading causes of global mortality and morbidity; their haunting trend has been predicted to rise, parallel to higher economic development [1] . The improvement of patient lipid profile is a challenge to decrease CVD mortality through prevention of atherosclerotic injuries. Several drugs help to reduce plasma LDL-C levels, but these synthetic medications also produce adverse effects such as diarrhea, nausea, myositis and abnormal liver function [2] . Moreover, some patients are resistant or intolerant to conventional pharmacotherapy. Therefore, alternative approaches are eagerly needed; plant-based therapies attract much interest as they are effective in reducing lipid levels [3] . The treatment for hypercholesterolemia and CVDs with medicinal plants has increased and seems to produce lower undesirable side effects [4] . Several reports have shown that herbal medicine reduces lipid peroxidation in blood, has anti-cancer activity in vitro and it is useful for treating infectious disease [5] . Herbal medicine is used by up 80% population from developing countries, but few scientific studies have explored the safety and efficacy of these traditional remedies [1] . In this line, the papaya leaves have been used as a remedy for various disorders like cancer and infectious diseases [6] . Moreover, papaya leaf methanol extract showed a HDL-C raising effect that improving the CVD risks [7] . However, to our knowledge, no report of its hypolipidemic effect has been published. The objective of this study was to evaluate the hypolipidemic action of Carica papaya extract and its action on liver metabolic parameters of hypercholesterolemic rats.
Materials and Methods

Chemical Compounds and Plant Products
All chemicals were purchased from Sigma (St Louis, Mo, USA). Other chemicals of analytical grade were obtained from Merck. Kits for different enzyme assays were purchased from Biosystems S.A., Mexico. The Carica papaya leaves were collected from June to September 2012 from Cintalapa, in the state of Chiapas, Mexico.
Preparation of C. papaya Leaf Chloroform Extract
The leaves of C. papaya were washed with tap water and cut into small slices. The slices were powdered after air-drying. A 100 g dry sample was placed in a Soxhlet system, the extraction was conducted 8 hours with 500 mL of chloroform. Subsequently, the solvent was evaporated in vacuum until the extract was completely dried and was preserved at −20˚C. Finally, 10 g of semi-solid mass was obtained.
Animals and Their Diets
Experiments were performed using male Wistar rats to avoid any gender differences due to sexual hormones, in the case of female rats [8] . At 7 weeks of age and 180 -200 g body weight were maintained under controlled housing conditions: 55% humidity, 21˚C ± 1˚C temperature and a 12 -12 h light-dark cycle, with free access to food and water. All experiments started at the same hour (10:00 AM) and they complied with the Guidelines on Ethical Standards for the investigation in animals; the project was approved by the local Internal Committee for the care and use of laboratory animals (003-13/CICUAL/DACS). The normal diet (ND), from Harlan Laboratories, contained 18.6% protein, 44.2% carbohydrates, 6.2% fat. The hypercholesterolemic diet (HD) included 2% cholesterol, 0.6% sodium deoxycholate added to grinded ND.
Study Design
The design of this study included the following groups (n = 8 each one): 1) ND: Normal diet; 2) ND + C. papaya extract: (62 mg/kg; ND + 62); 3) HD: Hypercholesterolemic diet; 4) HD + C. papaya extract (31 mg/kg; HD + 31); 5) HD + C. papaya extract: (62 mg/kg; HD + 62); 6) HD + C. papaya extract: (125 mg/kg; HD + 125).
Animals were given free access to water and food during the 20-day experimental time. At the end of treatment and after 12 h food withdrawal, the rats were sacrificed by decapitation. The liver was removed, weighted and 0.5 g of tissue was used for biochemical analyses, a small part was fixed in 10% buffered formaldehyde solution and the remaining tissue was used to isolate mitochondria and to assay respiratory function. C. papaya extract doses (31, 62 and 125 mg/kg/day) were given daily by oral gavage in 300 µl polyethylene glycol. These dose were chosen in accordance with previous experiments from our laboratory.
Biochemical Parameters
Serum levels of glucose, cholesterol, triacylglycerols, high-density lipoprotein-cholesterol (HDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) were evaluated. The atherogenic index (A.I.) was calculated according to the equations of Kim et al. [9] . Liver lipids were extracted according to the Folch et al. [10] procedure; triacylglycerols (TAG) and cholesterol concentrations were measured using enzymatic determination from BioSystems Laboratories.
Mitochondria Isolation
Hepatic tissue was washed twice with 250 mM sucrose, 0.5 mM HEPES, 0.5 mM EGTA buffer (SHE), and homogenized in SHE, pH 7.2, employing approximately 5 mL/g wet weight. Mitochondria were isolated by differential centrifugation and suspended with SHE to a final protein concentration of 0.5 mg/mL, determined by the Bradford method [11] .
Oxygen Consumption
Respiratory measurements of mitochondria were performed in 3.5 ml of air-saturated medium with 5 mM succinate, 2 mM MgCl 2 , 2 mM H 3 PO 4 , 2 mM EGTA, 30 mM HEPES, 0.1% BSA, pH 7.2, at 24˚C. Oxygen consumption was determined using a Clark-type oxygen electrode. Data are expressed as the respiratory control (RC) ratio, which is a relative value of state 3 and state 4 that indicates the respiratory coupling in availability of ADP [12] .
Liver Histopathological Examination
The histopathologic analysis was performed by light microscopy, staining with hematoxylin and eosin (HE). Other liver section was frozen and also sliced to be stained with Oil Red O to measure the steatosis areas in the liver by the Image Pro Plus 7.0 program [13] .
Statistical Analysis
One-way analysis of variance (ANOVA) followed by Student-Newman-Keuls test was used to compare differences between treatments. Values were considered statistically significant when p < 0.05.
Results
The Hypolipidemic and Antiatherogenic Effects of C. papaya Leaf
We observed that administration of a cholesterol-rich diet (HD) produced high levels of plasma cholesterol (249.3 ± 6.4 mg/dL) compared with normal diet (ND) (74.3 ± 2.2 mg/dL); besides, the treatment with different doses of C. papaya extract (HD + 31, HD + 62 and HD + 125) produced significant lower levels in a dose dependent manner (p < 0.05) ( mg/dL) in comparison with ND (60.4 ± 3.9 mg/dL) but the administration of C. papaya extract did not decrease significantly TAG levels in HD + 31 and HD + 62 in comparison with HD while HD + 125 showed similar TAG levels to those of HD rats ( Table 1) .
The HD rats showed a decrease in serum HDL-C levels (16.1 ± 0.3 mg/dL) compared with ND (34.9 ± 3.9 mg/dL); in addition, the three doses of C. papaya increased HDL-C levels with respect to HD ( Table 1) 
Liver Cholesterol and Triacylglycerols
The hepatic cholesterol levels of HD (13 ± 0.6 mg/g tissue) were significantly higher than those in ND (6 ± 0.2 mg/g tissue). In C. papaya-treated groups 31, 62 and 125 (9.9 ± 0.5, 9.4 ± 0.4, 10 ± 0.4 mg/g tissue; respectively) cholesterol levels were lower with respect to HD (p < 0.05). The liver TAG levels increased in HD (11 ± 0.2 mg/g tissue) compared to ND (7.3 ± 0.6 g mg/g tissue). However, a non-significant decrease was observed in C. papaya-treated groups 31, 62 and 125 (9.9 ± 0.4, 8.9 ± 0.7, 9.5 ± 0.8 mg/g tissue, respectively).
Liver Histopathological Examination (Hematoxylin & Eosin)
Hepatocytes from ND rats showed normal cell structure with well-preserved cytoplasm (Figure 1(a) ), containing small fat vesicles and glycogen granules, with no signs of fibrosis. The liver morphology of ND + 62 rats (Figure 1(b) ) showed similar characteristics than those observed in ND rats. On the other hand, HD rats presented a multivesicular hepatic steatosis, with abundant fat vesicles and glycogen granules especially around the central veins (Figure 1(c) ). The liver morphology of HD + 31 and HD + 62 rats (Figure 1(d) & Figure 1(e) , respectively) exhibited moderate changes including a lower grade of steatosis in comparison with that observed in HD rats. The lipid-lowering effect of C. papaya extract was worthless in HD + 125 rats (Figure 1(f) ).
Oil Red O Staining
The ND livers (Figure 2(a) ) showed a minimal amount of lipid droplets, as well as the liver of ND + 62 rats (Figure 2(b) ). In HD group the liver shows a multivesicular steatosis (Figure 2(c) ). HD + 31 and HD + 62 rats (Figure 2(d) & Figure 2(e) , respectively) showed a lower grade of liver steatosis than HD group. Again, the effect of C. papaya extract on liver lipids was worthless in HD + 125 group (Figure 2(f) ). Additionally, the assay of the fatty area in hepatocytes of HD rats (198 ± 3.03 μm 2 ) was the highest value among all groups, in contrast to ND group values (4.48 ± 0.6 μm 2 ). On the other hand, HD + 31, HD + 62 and HD + 125 groups showed minor lipid areas (136 ± 19.9, 76.71 ± 8.14 and 133 ± 9.93 μm 2 , respectively) than that observed in HD rats (198 ± 3.03 μm 2 ). The HD + 62 group showed the most important decrease of liver lipids.
Respiratory Control
The respiratory control (RC) was lower in the liver mitochondria of HD rats (2 ± 0.2) in comparison with ND rats (3 ± 0.1). Groups HD + 31, HD + 62 and HD + 125 showed a significant increase of oxygen consumption 
Discussion
The high prevalence of chronic metabolic diseases around the world is associated with hyperlipidemia and development of CVD. For this reason, there is a considerable interest in finding new safe hypolipidemic drugs to prevent cardiovascular complications
The Hypolipidemic and Antiatherogenic Effects of C. papaya Leaf
We observed that treatment with C. papaya extract decreased serum cholesterol of HD rats. Previous reports from our laboratory have shown that C. papaya leaf contains sterols among their main components. It is known that phytosterols with analogue structure to cholesterol may decrease cholesterol absorption displacing it from bile salt micelles and competing for intestinal absorption [14] [15] . Intestinal absorption plays a main role in the regulation of cholesterol homeostasis. It has been suggested that transporters can affect its intestinal absorption [16] [17] . Silva et al. in 2013 [18] observed a reduction of hepatic cholesterol after β-carotene supplementation to rats with a cholesterol-rich diet, an effect attributed to increased cholesterol fecal excretion. Nowadays, the increase of serum LDL concentration and a high LDL/HDL ratio are considered atherogenic risk factors. In this sense, recent epidemiological and clinical studies have also shown a positive correlation between serum LDL-C levels and the risk of coronary heart disease [19] [20] . The administration of flavonoids to hyperlipidemic rats improves dyslipidemia [20] , decreases the intestinal absorption of cholesterol, besides the reabsorption of bile acids and neutral sterols. In the case of C. papaya, this could be the mechanism for serum cholesterol improvement. On the other hand, when phytosterols were given to hypercholesterolemic patients a significant reduction of LDL-C was produced [19] .
Liver Cholesterol, Triacylglycerols and Histopathological Changes by C. papaya Leaf
Liver is the main site for cholesterol homeostasis and a high fat diet increases the lipid levels in content of the liver. Previous studies have demonstrated that a cholesterol-rich diet can induce steatohepatitis in animal models [21] . Hepatic damage is related to deterioration of the hepatocyte membrane, which generates a reduction of its antioxidant and detoxification capacity [20] . In this study we observed that C. papaya administrated to HD rats reduced hepatic cholesterol.
This result is in accordance with other reports after plant extracts administration [21] . Other plant extracts given to hypercholesterolemic rats inhibited the 3-hydroxy-3-methylglutaryl-CoA reductase. In this study, the C. papaya extract given to HD rats did not reduce the liver TAG, a lacking effect also observed on serum TAG levels. Other studies suggest that plant extracts reduce hyperlipidemia and fatty liver through an increase of fatty acid oxidation, and lower TAG synthesis, which leads to a rise of steroid fecal excretion with minor alteration of cholesterol synthesis [22] .
It's known that a cholesterol-rich diet can induce steatohepatitis in animal models; this damage is related to deterioration of the hepatocyte membrane, which generates a reduction of its antioxidant and detoxification capacity [20] . The increase in serum transaminases has been considered a marker of liver damage. In this study, serum ALT and ALP improved after C. papaya (62 mg/kg) treatment. Furthermore, the histopathological studies in HD + 62 liver showed a reduced damage due to decrease of cholesterol in hepatocyte. In this sense, other reports have informed that diminishing free-radicals production, after plant extract administration, may protect the liver from the high-cholesterol toxicity [23] [24] . Recently, other reports suggest that plant extracts can inhibit free fatty acid (FFA) transport into the liver and regulate FFA metabolism through the expression of related genes [24] . In our study we observed that C. papaya leaf extract significantly decreased serum glucose levels in HD + 31, HD + 62 and HD + 125 compared with HD (p < 0.05). Some studies have suggested that plant sterols may delay the glucose absorption by inhibiting intestinal enzymes that hydrolyze carbohydrates with the concomitant lower glycemia [14] .
Effect of C. papaya Leaf on the Respiratory Control
It is known that mitochondria are affected by a high fat diet, presenting ultra-structural abnormalities and higher production of reactive oxygen species (ROS) that produce hepatic cellular damage [25] [26] . Our results showed that HD rats present a decrease of the respiratory control in comparison with ND rats. Other authors have reported a reduction in oxygen consumption, phosphorylation rate and hepatic mitochondria respiratory control in HD rats [26] [27] . We observed that C. papaya leaf administered to HD rats improved the respiratory control. There is evidence that flavonoids, saponins and polyphenols, raise the antioxidant system activity and reduce the nitric oxide production in the hypercholesterolemic rats. The C. papaya antioxidant effect may reduce the oxidative stress due to hypercholesterolemia, resulting in a reduction or a delay of the liver endothelial cells harm.
Conclusion
In the present study, the administration of C. papaya chloroform extract to rats with a cholesterol-rich diet showed a hypoglycemic and hypolipidemic effect, with reduction of the atherogenic index, minor hepatic damage and increased respiratory function of the hepatic mitochondria. We speculate that these effects can be due to the sterol content of C. papaya, which is effective to reduce dietary cholesterol absorption. Consequently, the C. papaya leaf extract could be considered, along with other lifestyle changes, as an alternative treatment for hypercholesterolemic patients. Further studies are required in order to characterize the active substances in the extract and to understand their mechanism of action.
